Does the timing of estrogen administration after castration affect its ability to preserve sexual interest in male rats? - Exploring the critical period hypothesis

Physiology and Behavior

Volumn 110-111, Issue , 2013, Pages 63-72

  Wibowo, Erik ^a   Wassersug, Richard J ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Androgen deprivation; Castration; Critical period hypothesis; Estradiol; Libido; Mounting; Sexual interest

Indexed keywords

ESTRADIOL; OIL;

ANDROGEN DEPRIVATION THERAPY; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CASTRATED MALE; CASTRATION; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOIMMUNOASSAY; RAT; SEXUAL BEHAVIOR;

EID: 84872728137     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.12.010     Document Type: Article

References (53)

1. Smith M.R. Androgen deprivation therapy for prostate cancer: new concepts and concerns. Curr Opin Endocrinol Diabetes Obes 2007, 14:247-254.
2. Higano C. Androgen deprivation therapy: monitoring and managing the complications. Hematol Oncol Clin North Am 2006, 20:909-923.
3. Wibowo E., Schellhammer P.F., Wassersug R. Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy. J Urol 2011, 185:17-23.
4. Wibowo, E, Wassersug, RJ. The effect of estrogen on the sexual interest in castrated males: implications to men on androgen-deprivation therapy. Crit Rev Oncol Hematol. in press.
5. Wibowo E., Wassersug R., Warkentin K., Walker L., Robinson J., Brotto L., et al. Impact of androgen deprivation therapy on sexual function: a response. Asian J Androl 2012, 14:793-794.
6. Clark C.R., MacLusky N.J., Parsons B., Naftolin F. Effects of estrogen deprivation on brain estrogen and progestin receptor levels and the activation of female sexual behavior. Horm Behav 1981, 15:289-298.
7. Damassa D., Davidson J.M. Effects of ovariectomy and constant light on responsiveness to estrogen in the rat. Horm Behav 1973, 4:269-279.
8. Czaja J.A., Butera P.C. Behavioral consequences of hormonal deprivation on the responsiveness of female rats to estradiol. Physiol Behav 1985, 35:873-877.
9. Sherwin B.B. Estrogen therapy: is time of initiation critical for neuroprotection?. Nat Rev Endocrinol 2009, 5:620-627.
10. Daniel J.M., Bohacek J. The critical period hypothesis of estrogen effects on cognition: insights from basic research. Biochim Biophys Acta 2010, 1800:1068-1076.
11. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis 2010, 7:163-166.
12. Scott E., Zhang Q.G., Wang R., Vadlamudi R., Brann D. Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol 2012, 33:85-104.
13. Guise T.A., Oefelein M.G., Eastham J.A., Cookson M.S., Higano C.S., Smith M.R. Estrogenic side effects of androgen deprivation therapy. Rev Urol 2007, 9:163-180.
14. Olivier B., Chan J.S., Pattij T., de Jong T.R., Oosting R.S., Veening J.G., et al. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions?. Int J Impot Res 2006, 18(Suppl. 1):S14-S23.
15. Wibowo E., Deurveilher S., Wassersug R.J., Semba K. Estradiol treatment modulates spontaneous sleep and recovery after sleep deprivation in castrated male rats. Behav Brain Res 2012, 226:456-464.
16. Ottoni E.B. EthoLog 2.2: a tool for the transcription and timing of behavior observation sessions. Behav Res Methods Instrum Comput 2000, 32:446-449.
17. Agmo A. Male rat sexual behavior. Brain Res Protoc 1997, 1:203-209.
18. Davidson J.M. Effects of estrogen on the sexual behavior of male rats. Endocrinology 1969, 84:1365-1372.
19. Södersten P. Estrogen-activated sexual behavior in male rats. Horm Behav 1973, 4:247-256.
20. Södersten P., Larsson K. Lordosis behavior and mounting behavior in male rats: effects of castration and treatment with estradiol benzoate or testosterone propionate. Physiol Behav 1975, 14:159-164.
21. Davidson J.M. Characteristics of sex behaviour in male rats following castration. Anim Behav 1966, 14:266-272.
22. Sengelaub D.R., Forger N.G. The spinal nucleus of the bulbocavernosus: firsts in androgen-dependent neural sex differences. Horm Behav 2008, 53:596-612.
23. Holmes G.M., Sachs B.D. Erectile function and bulbospongiosus EMG activity in estrogen-maintained castrated rats vary with behavioral context. Horm Behav 1992, 26:406-419.
24. Fargo K.N., Foster A.M., Harty M.W., Sengelaub D.R. Estrogen alters excitability but not morphology of a sexually dimorphic neuromuscular system in adult rats. J Neurobiol 2003, 56:66-77.
25. Foster A.M., Sengelaub D.R. Hormone sensitivity of muscle activation in the sexually dimorphic SNB/BC neuromuscular system of the rat. Neurosci Lett 2004, 359:41-44.
26. Hull E.M., Wood R.I., McKenna K.E. Neurobiology of male sexual behavior. Knobill's and Neill's physiology of reproduction 2006, 1729-1824. Elsevier, St. Louis, MO. 3rd ed. J.D. Neill (Ed.).
27. Shishkina G.T., Kalinina T.S., Sournina N.Y., Dygalo N.N. Effects of antisense to the (alpha)2A-adrenoceptors administered into the region of the locus ceruleus on behaviors in plus-maze and sexual behavior tests in sham-operated and castrated male rats. J Neurosci 2001, 21:726-731.
28. Cross E., Roselli C.E. 17beta-estradiol rapidly facilitates chemoinvestigation and mounting in castrated male rats. Am J Physiol 1999, 276:R1346-R1350.
29. Roselli C.E., Chambers K. Sex differences in male-typical copulatory behaviors in response to androgen and estrogen treatment in rats. Neuroendocrinology 1999, 69:290-298.
30. Antliff H.R., Young W.C. Behavioral and tissue responses of male guinea pigs to estrogens and the problem of hormone specificity. Endocrinology 1956, 59:74-82.
31. Sodersten P., Larsson K. Lordosis behavior in castrated male rats treated with estradiol benzoate or testosterone propionate in combination with an estrogen antagonist, MER-25, and in intact male rats. Horm Behav 1974, 5:13-18.
32. Flanagan-Cato L.M. Sex differences in the neural circuit that mediates female sexual receptivity. Front Neuroendocrinol 2011, 32:124-136.
33. Handa R.J., Kerr J.E., DonCarlos L.L., McGivern R.F., Hejna G. Hormonal regulation of androgen receptor messenger RNA in the medial preoptic area of the male rat. Mol Brain Res 1996, 39:57-67.
34. Bohacek J., Daniel J.M. The ability of oestradiol administration to regulate protein levels of oestrogen receptor alpha in the hippocampus and prefrontal cortex of middle-aged rats is altered following long-term ovarian hormone deprivation. J Neuroendocrinol 2009, 21:640-647.
35. Gentry R.T., Wade G.N. Androgenic control of food intake and body weight in male rats. J Comp Physiol Psychol 1976, 90:18-25.
36. Gentry R.T., Wade G.N. Sex differences in sensitivity of food intake, body weight, and running-wheel activity to ovarian steroids in rats. J Comp Physiol Psychol 1976, 90:747-754.
37. Braga-Basaria M., Dobs A.S., Muller D.C., Carducci M.A., John M., Egan J., et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 2006, 24:3979-3983.
38. Purnell J.Q., Bland L.B., Garzotto M., Lemmon D., Wersinger E.M., Ryan C.W., et al. Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer. J Lipid Res 2006, 47:349-355.
39. Elliott S., Latini D.M., Walker L.M., Wassersug R., Robinson J.W. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. J Sex Med 2010, 7:2996-3010.
40. Kim Y., Kashy D.A., Wellisch D.K., Spillers R.L., Kaw C.K., Smith T.G. Quality of life of couples dealing with cancer: dyadic and individual adjustment among breast and prostate cancer survivors and their spousal caregivers. Ann Behav Med 2008, 35:230-238.
41. Walker L.M., Robinson J.W. A description of heterosexual couples' sexual adjustment to androgen deprivation therapy for prostate cancer. Psychooncology 2011, 20:880-888.
42. Soloway C.T., Soloway M.S., Kim S.S., Kava B.R. Sexual, psychological and dyadic qualities of the prostate cancer 'couple'. BJU Int 2005, 95:780-785.
43. Navon L., Morag A. Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties. Qual Health Res 2003, 13:1378-1392.
44. Brett M.A., Roberts L.F., Johnson T.W., Wassersug R.J. Eunuchs in contemporary society: expectations, consequences, and adjustments to castration (part II). J Sex Med 2007, 4:946-955.
45. Davidson J.M., Camargo C., Smith E.R., Kwan M. Maintenance of sexual function in a castrated man treated with ovarian steroids. Arch Sex Behav 1983, 12:263-274.
46. Ellis W.J., Grayhack J.T. Sexual function in aging males after orchiectomy and estrogen therapy. J Urol 1963, 89:895-899.
47. Bergman B., Damber J.E., Littbrand B., Sjogren K., Tomic R. Sexual function in prostatic cancer patients treated with radiotherapy, orchiectomy or oestrogens. Br J Urol 1984, 56:64-69.
48. Wassersug R.J., Gray R. The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: a qualitative study with comments on expectations and estrogen. Psychol Health Med 2011, 16:39-52.
49. Ockrim J.L., Lalani el N., Kakkar A.K., Abel P.D. Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism. J Urol 2005, 174:527-533.
50. Hedlund P.O., Damber J.E., Hagerman I., Haukaas S., Henriksson P., Iversen P., et al. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scand J Urol Nephrol 2008, 42:220-229.
51. Schellhammer P. Life after failure of traditional androgen deprivation therapy. Urol Oncol 2012, 30:S10-S14.
52. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011, 1379:188-198.
53. Ockrim J.L., Lalani el, N., Banks L.M., Svenson W.E., Blomley M.J., Patel S., et al. Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer. J Urol 2004, 172:2203-2207.